Vanguard Group’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
|
|||||
2024
Q4 | $353K | Hold |
|
|||||
2024
Q3 | $472K | Buy |
|
|||||
2024
Q2 | $567K | Buy |
|
|||||
2024
Q1 | $551K | Buy |
|
|||||
2023
Q4 | $565K | Buy |
|
|||||
2023
Q3 | $400K | Buy |
|
|||||
2023
Q2 | $414K | Buy |
|
|||||
2023
Q1 | $213K | Hold |
|
|||||
2022
Q4 | $361K | Buy |
|
|||||
2022
Q3 | $490K | Hold |
|
|||||
2022
Q2 | $500K | Sell |
|
|||||
2022
Q1 | $808K | Buy |
|
|||||
2021
Q4 | $948K | Buy |
|
|||||
2021
Q3 | $1.16M | Buy |
|
|||||
2021
Q2 | $1.55M | Buy |
|
|||||
2021
Q1 | $276K | Buy |
|